Karrox-CV Dry Syrup Mango is a pediatric antibiotic formulation containing Amoxycillin 200 mg and Clavulanic Acid 28.5 mg per 5 ml reconstituted suspension. Amoxycillin, a broad-spectrum penicillin antibiotic, inhibits bacterial cell wall synthesis, leading to bacterial cell death. Clavulanic Acid, a beta-lactamase inhibitor, protects Amoxycillin from enzymatic degradation by beta-lactamase-producing bacteria, thereby extending its spectrum of activity. This combination is effective against a wide range of Gram-positive and Gram-negative pathogens responsible for respiratory tract infections, otitis media, sinusitis, skin and soft tissue infections, and urinary tract infections in pediatric patients. Karrox-CV Dry Syrup Mango is indicated for use in children where oral antibiotic therapy is appropriate and provides a palatable mango-flavored formulation to enhance compliance. The dosing regimen should be determined based on the severity of infection and patient weight, as per physician’s guidance. It is contraindicated in patients with a history of hypersensitivity to penicillins or beta-lactamase inhibitors. Caution is advised in patients with hepatic impairment. Common adverse effects may include gastrointestinal disturbances such as diarrhea, nausea, and vomiting. Proper reconstitution and storage conditions must be followed to maintain drug stability and efficacy.